Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON30643
NL-OMON30643CompletedPhase 2

Probiotics in atherosclerosis: a pilot study - Probiotics in atherosclerosis

Academisch Ziekenhuis Maastricht0 sites10 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
10
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •patients with ANCA associated vasculits
  • •increased CD4+/CD28- T-cell counts

Exclusion Criteria

  • •No significant immunosupressive therapy

Investigators

Similar Trials

Completed
Not Applicable
Effect of Probiotics on Cardiometabolic HealthCardiometabolic Risk Factors
NCT05005754Sun Yat-sen University130
Recruiting
Not Applicable
PRIMAL Clinical Study: Efficacy of probiotics to prevent gut dysbiosis in very preterm infants (VPIs) and moderate preterm infants of 28+0 – 32+6 weeks of gestation: A randomized, placebo-controlled double-blind studyK63.8Other specified diseases of intestine
DRKS00013197niversitätsklinikum Schleswig-Holstein654
Completed
Not Applicable
A pilot study on the clinical effect of probiotics "Yasainosenshi" among patients with mild to moderate ulcerative colitis.ulcerative colitis
JPRN-UMIN000019753Shiga University of Medical Science30
Not yet recruiting
Phase 3
Role of probiotics intake on the disease course of arthritis in children.
CTRI/2023/12/060403Indian Rheumatology Association
Not yet recruiting
Not Applicable
Het effect van probiotica op vitamine K status
NL-OMON21670VU medical center Amsterdam20